Brokerage consensus turns bullish on seven Indian stocks, with target prices signalling up to 78% upside across banking, ...

We came across a bullish thesis on Becton, Dickinson and Company on X.com by @MoneyShow. In this article, we will summarize ...

Novartis becomes the second company to settle after being accused of reaping rewards from a racist medical system.

Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the best cancer stocks to invest in now. On February 26, Revolution Medicines, Inc. (NASDAQ:RVMD) CEO Mark A. Goldsmith reiterated that the company ...

As pharma DTC platforms continue to expand, regulators will keep an eye on how discounted drugs are sold — and even advertised — in ways that don’t violate anti-kickback laws.

Hikma Pharmaceuticals PLC ( HKMPY) Q4 2025 Earnings Call February 25, 2026 7:00 PM EST ...

Rare disease researchers have long known that viewing each patient as a source of insight rather than a single data point is critical to developing the most effective treatments.

Chicago-based Xeris Biopharma has hauled two generic rivals into federal court, filing suit on Tuesday to stop would-be ...

BioNTech and partner DualityBio are accelerating the development of their B7-H3 antibody-drug conjugate into a phase 3 trial for metastatic castration-resistant prostate cancer (mCRPC). | BioNTech and ...

Henrietta Lacks’ cells were the first to reproduce in a laboratory, outside the human body, and have been used in ...

Hospitals and safety net clinics in Minnesota received $1.34 billion in 2024 from an obscure medicine discount program Congress created in the 1990s to help fund heath care for low-income people ...